Functional characterization of a novel transcript of ERCC1 in chemotherapy resistance of ovarian cancer

Approximately 15-20% of ovarian cancer patients receiving platinum-based chemotherapy are primary platinum-resistant. Identification of these patients and transfer to other more effective therapy could reduce the morbidity of ovarian cancer. ERCC1 is a DNA repair gene which can complex with XPF to r...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Zhang, Lin, Mao, Ping, Jiang, Guoqiang, Liu, Likun, Wang, Jing, Yang, Wei, Owusu, Lawrence, Li, Weiling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689644/
https://www.ncbi.nlm.nih.gov/pubmed/29156754
http://dx.doi.org/10.18632/oncotarget.20482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689644/
https://www.ncbi.nlm.nih.gov/pubmed/29156754
http://dx.doi.org/10.18632/oncotarget.20482

Ejemplares similares